Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  1989-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.7164/ANTIBIOTICS.42.674PMID 2498275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.

  1989cited by this paper
• Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

  1989cited by this paper
• The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it.

  1985cited by this paper
• An evaluation of antipseudomonal antimicrobic agents.

  1985cited by this paper
• THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

  1974cited by this paper
• THE BARRIER FUNCTION OF THE GRAM‐NEGATIVE ENVELOPE

  1974cited by this paper

• Computational prediction of CNP0387675 as a non-nucleoside inhibitor of MraY, from natural product-based multi-template screening against Pseudomonas aeruginosa

  2025cites this paper
• MraY: An emerging therapeutic target in bacterial peptidoglycan biosynthesis for the discovery of novel antibiotics from natural and synthetic origin.

  2025cites this paper
• Miniaturized Cultivation Profiling (MATRIX)-Facilitated Discovery of Noonazines A–C and Noonaphilone A from an Australian Marine-Derived Fungus, Aspergillus noonimiae CMB-M0339

  2024cites this paper
• Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY

  2022cites this paper
• Cell wall deficiency - an alternate bacterial lifestyle?

  2022cites this paper
• Molecular mechanism of mureidomycin biosynthesis activated by introduction of an exogenous regulatory gene ssaA into Streptomyces roseosporus

  2021cites this paper
• Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.

  2021cites this paper
• tRNA-dependent amide bond-forming enzymes in peptide natural product biosynthesis.

  2020cites this paper
• Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.

  2020cites this paper
• Merging Natural Products: Muraymycin–Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents

  2020cites this paper
• Elucidating the Structural Requirement of Uridylpeptide Antibiotics for Antibacterial Activity.

  2020cites this paper
• Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis

  2019cites this paper
• Chemical logic of MraY inhibition by antibacterial nucleoside natural products

  2019cites this paper
• Muraminomicins, novel ester derivatives: in vitro and in vivo antistaphylococcal activity

  2019cites this paper
• Mechanism of action of nucleoside antibacterial natural product antibiotics

  2019cites this paper
• Crystal structure of MraY bound to carbacaprazamycin

  2019cites this paper
• Nucleoside Natural Product Antibiotics Targetting Microbial Cell Wall Biosynthesis

  2017cites this paper
• Bacterial phosphoglycosyl transferases: initiators of glycan biosynthesis at the membrane interface

  2017cites this paper
• Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action

  2016cites this paper
• Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents

  2016cites this paper
• The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic Targets

  2016cites this paper
• Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship.

  2015cites this paper
• Identification of novel mureidomycin analogues via rational activation of a cryptic gene cluster in Streptomyces roseosporus NRRL 15998

  2015cites this paper
• Priming and processing glycosyltransferases in bacterial N-linked glycosylation pathways

  2015cites this paper
• NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.

  2014cites this paper
• Cu-mediated enamide formation in the total synthesis of complex peptide natural products.

  2014cites this paper
• Anti-antimicrobial Peptides

  2013cites this paper
• Viable screening targets related to the bacterial cell wall

  2013cites this paper
• Identification of Mureidomycin Analogues and Functional Analysis of an N‐Acetyltransferase in Napsamycin Biosynthesis

  2013cites this paper
• Antibiotics for Emerging Pathogens

  2013cites this paper
• Anti-antimicrobial Peptides FOLDING-MEDIATED HOST DEFENSE ANTAGONISTS

  2013cites this paper
• Total synthesis and biological evaluation of pacidamycin D and its 3'-hydroxy analogue.

  2012cites this paper
• The role of the outer membrane of Gram-negative bacteria in antibiotic resistance: Ajax' shield or Achilles' heel?

  2012cites this paper
• Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction.

  2012cites this paper
• Rational Approaches to Antibacterial Discovery: Pre-Genomic Directed and Phenotypic Screening

  2012cites this paper
• Identification of a Napsamycin Biosynthesis Gene Cluster by Genome Mining

  2011cites this paper
• Update 1 of: α,β-Diamino acids: biological significance and synthetic approaches.

  2011cites this paper
• Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis.

  2010cites this paper
• Terrestrial Microorganisms – Filamentous Bacteria

  2010cites this paper
• Cell Wall Targeted Antibiotics

  2010cites this paper
• Biosynthesis of liponucleoside antibiotics in Streptomyces : Molecular and biochemical investigations of the caprazamycin and the liposidomycin gene cluster

  2010influential citation
• New Pacidamycin Antibiotics Through Precursor‐Directed Biosynthesis

  2009cites this paper
• Identification of a novel beta-replacement reaction in the biosynthesis of 2,3-diaminobutyric acid in peptidylnucleoside mureidomycin A.

  2008cites this paper
• Bacterial Cell Wall Components

  2008cites this paper
• Biogenetic hypothesis and first steps towards a biomimetic synthesis of haouamines.

  2007cites this paper
• Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.

  2007cites this paper
• Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library.

  2007cites this paper
• NewPacidamycins Produced by Streptomyces coeruleorubidus , NRRL 1 8370

  2006cites this paper
• MraY Inhibitors as Novel Antibacterial Agents.

  2005cites this paper
• Alpha,beta-diamino acids: biological significance and synthetic approaches.

  2005cites this paper
• The Leptomycin Gene Cluster and Its Heterologous Expression in Streptomyces lividans

  2005cites this paper
• A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.

  2004cites this paper
• Phospho-N-Acetyl-Muramyl-Pentapeptide Translocase from Escherichia coli: Catalytic Role of Conserved Aspartic Acid Residues

  2004cites this paper
• Synthesis and activity of 5'-uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A.

  2003cites this paper
• Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class.

  2003cites this paper
• Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.

  2003cites this paper
• Synthesis of base-modified dihydropacidamycins.

  2002cites this paper
• Stereochemical elucidation and total synthesis of dihydropacidamycin D, a semisynthetic pacidamycin.

  2001cites this paper
• The Lysis Protein E of φX174 Is a Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis*

  2001cites this paper
• New pacidamycins produced by Streptomyces coeruleorubidus, NRRL 18370.

  2000cites this paper
• Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis.

  2000cites this paper
• Nucleosides and Nucleotides

  2000cites this paper
• A solid-phase approach to analogues of the antibiotic mureidomycin.

  2000cites this paper
• Targeting cell wall synthesis and assembly in microbes: similarities and contrasts between bacteria and fungi.

  1999cites this paper
• Role of the enamide linkage of nucleoside antibiotic mureidomycin A: synthesis and reactivity of enamide-containing analogues

  1999cites this paper
• Antibiotic resistance versus small molecules, the chemical evolution

  1999cites this paper
• 3.10 – Bacterial Peptidoglycan Biosynthesis and its Inhibition

  1999cites this paper
• Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli

  1996cites this paper
• Slow Binding Inhibition of Phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by Mureidomycin A (*)

  1996cites this paper
• Mureidomycins E and F, minor components of mureidomycins.

  1993cites this paper
• Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins

  1993cites this paper
• Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins

  1992cites this paper
• Current progress on nucleoside antibiotics.

  1991cites this paper
• Detection of novel secondary metabolites.

  1991cites this paper
• Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis

  1991cites this paper
• Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

  1989cites this paper
• Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.

  1989cites this paper